The physiological disposition of (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in the rat, dog, rhesus monkey, and baboon
- PMID: 26553
The physiological disposition of (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in the rat, dog, rhesus monkey, and baboon
Similar articles
-
The metabolism of (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in chimpanzee and man.Drug Metab Dispos. 1978 May-Jun;6(3):303-12. Drug Metab Dispos. 1978. PMID: 26552
-
The physiological disposition of the uricosuric-saluretic agent (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy)acetic acid (MK-196) in the rat, dog, and monkey.Drug Metab Dispos. 1976 Sep-Oct;4(5):490-8. Drug Metab Dispos. 1976. PMID: 10149
-
GLC determination of the polyvalent saluretic uricosuric agent (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in biological fluids.J Pharm Sci. 1978 Feb;67(2):162-4. doi: 10.1002/jps.2600670210. J Pharm Sci. 1978. PMID: 413902
-
Physiological disposition of caffeine.Drug Metab Rev. 1975;4(2):199-228. doi: 10.3109/03602537508993756. Drug Metab Rev. 1975. PMID: 816628 Review. No abstract available.
-
Interaction of drug metabolism with the other elements of drug safety evaluation.Drug Metab Rev. 1975;4(1):115-33. doi: 10.3109/03602537508993751. Drug Metab Rev. 1975. PMID: 812688 Review. No abstract available.
Cited by
-
Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment.Eur J Drug Metab Pharmacokinet. 1993 Jan-Mar;18(1):31-9. doi: 10.1007/BF03220006. Eur J Drug Metab Pharmacokinet. 1993. PMID: 8335037 Review.
-
Differences in toxicity due to species variation in the metabolism of an oral anti-allergy agent [proceedings].Br J Pharmacol. 1979 Jul;66(3):422P-423P. Br J Pharmacol. 1979. PMID: 43174 Free PMC article. No abstract available.
-
Metabolism and clearance of proxicromil--studies in rat, hamster, rabbit, dog, squirrel monkey, cynomolgus monkey, baboon and man.Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):225-32. doi: 10.1007/BF03188752. Eur J Drug Metab Pharmacokinet. 1983. PMID: 6653614